The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amit Bhupendra Halvawala & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 2.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Amit Bhupendra Halvawala, along with 12 persons acting in concert (PACs), acquired a total of 5,93,400 convertible equity warrants of Trident Lifeline Limited on June 9, 2025 under a preferential offer. Individually, Amit Bhupendra Halvawala picked up 1,39,800 warrants, while other PACs including the Hardik Desai Family Trust (1,89,000), Maniya H Desai (99,000), and others received the balance. Before the acquisition, the promoter and PAC group held 72,49,400 shares (63.04% voting rights). After the warrant allotment, the total holding rises to 78,42,800 shares/warrants — voting rights remain at 63.04%, but on a fully diluted basis (assuming warrant conversion) the group's stake increases to 67.79%. The diluted share capital rises from 1,14,99,200 to 1,24,93,400 equity shares. Equity share capital remains unchanged at Rs. 11,49,92,000.
This is a positive signal of promoter confidence, as the promoter group is increasing its economic interest in the company through a preferential warrant allotment. However, it also means potential dilution for existing public shareholders if and when these warrants are converted into equity shares.